This pattern persists throughout the life span of men and throughout the reproductive ages of women.11,13 Postmenopausal women have an increase in both total adipose tissue volume and VAT volume, as compared with premenopausal women. The increase in VAT in older women has been demonstrated to first occur around the ages of 40-50 years and again from 50 to
60 years of age.11,13 Given that adipose tissue distribution varies by age and reproductive status, we distinguish PD-1/PD-L1 inhibitor between 2 categories: (1) studies that specifically recruited peri- and postmenopausal women or whose mean age of participants was over 50 (predominantly peri- & post-reproductive age); and (2) studies whose mean age was under 50 years of age or whose methods did not specifically recruit peri- and postmenopausal women (predominantly reproductive age). Obesity and Migraine
in Reproductive-Age Participants.— In 2005, 2 small clinic-based studies reported an increased frequency of migraine attacks in those with TBO (Table 4).28,29 In the first, Peres et al compared 74 patients with TBO (mean age of 39 years) who presented to an obesity surgery clinic to 70 age-matched controls.28 A total of 75% of those with TBO had a life-time headache diagnosis as compared with 42% of the controls, this website P < .001. Furthermore, ICHD migraine was reported by 66% of those with TBO as compared with 18.5% of the non-obese controls, P < .0001. Similarly, in the second clinic-based study by Horev et al, 63% of 27 patients with TBO reported episodic headache and 48% fulfilled migraine criteria.29 These 2 studies were subsequently followed by 4 cross-sectional, general population-based studies evaluating obesity in those of reproductive age with varying results.14,30-32 One of these MCE公司 studies found
no association between migraine prevalence and TBO;30 another found no association between migraine prevalence and TBO, but did find an association between headache prevalence and obesity.31 The other 2 studies reported a positive association between the prevalence of migraine or severe headaches and obesity.14,32 In the first of the general population studies, Bigal et al evaluated 30,215 participants, of whom 3791 fulfilled ICHD migraine criteria and 25,150 were controls (Table 3).30 The age of participants ranged from 18 to 89 years with a mean of 39 years. TBO was estimated using self-reported height and weight. Several findings from this study are of note. First, the crude and adjusted prevalence of migraine was increased in women who were underweight. In addition the crude prevalence of migraine was increased in men with a BMI ≥ 35 (8.8%) as compared with men of normal weight (7.2%), P < .01; however, this finding did not remain significant after adjusting for demographics. Finally, although migraine prevalence was not found to be associated with self-reported BMI, the prevalence of high-frequency episodic migraine was associated with TBO. Specifically, while only 4.